Biotech · Private company
Medinol Ltd.
Track this companyFree. Adds Medinol Ltd. to your Dealase workspace and tells you when its record changes.
Clinical trials51 recruiting or active
Pipeline programs6From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline6
- BioNIRCoronary Artery StenosisClinicalTrials.gov · fetched Nov 12, 2026
- BioNIR Ridaforolimus Eluting Coronary StentHeart DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- ChampioNIR Ridaforolimus Eluting Peripheral Stent SystemSuperficial Femoral Artery StenosisClinicalTrials.gov · fetched Nov 12, 2026
- IoNIR Ridaforolimus-Eluting Coronary Stent SystemCoronary StenosisClinicalTrials.gov · fetched Nov 12, 2026
- ResoluteCoronary Artery StenosisClinicalTrials.gov · fetched Nov 12, 2026
- Stenting procedurede Novo Stenotic Lesions in Native Coronary ArteriesClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials5
- IonMAN II Trial- Early Feasibility Study of the IoNIR Ridaforolimus-Eluting Coronary Stent SystemNA · SUSPENDED · started Aug 7, 2025ClinicalTrials.gov NCT06071702 · fetched Nov 12, 2026
- First In Human Study to Assess Safety and Efficacy of the ChampioNIR™ Drug Eluting Peripheral Stent in the Treatment of Patients With Superficial Femoral Artery Disease and/or Proximal Popliteal Artery DiseaseNA · ACTIVE_NOT_RECRUITING · started Aug 15, 2024ClinicalTrials.gov NCT06410313 · fetched Nov 12, 2026
- BIONICS - Pharmacokinetics (PK) TrialCOMPLETED · started Apr 1, 2016ClinicalTrials.gov NCT02736344 · fetched Nov 12, 2026
- NIRTRAKS Post-Market Study (NIRTRAKS)NA · COMPLETED · started Jan 8, 2016ClinicalTrials.gov NCT02455804 · fetched Nov 12, 2026
- Study of BioNIR Drug Eluting Stent System in Coronary StenosisNA · COMPLETED · started Jan 1, 2014ClinicalTrials.gov NCT01995487 · fetched Nov 12, 2026